Patents Assigned to Target Therapeutics, Inc.
  • Patent number: 5733329
    Abstract: This is an implantable vaso-occlusive coil which is implanted using minimally invasive surgical techniques. It is a complex, helically wound coil made up of a primary helically wound coil which is then wound into a specific secondary shape. The secondary shape is itself a series of helical turns. At least a portion of the turns in the secondary shape form a cylindrical region and adjacent that region on at least one end is a conical region which tapers from a diameter approximating that of the central cylindrical region to a smaller diameter. The device is desirably self-forming upon exit from the distal end of a delivery catheter. Also, the conical tipped vaso-occlusive device may also utilize thrombus-enhancing filamentary material.
    Type: Grant
    Filed: December 30, 1996
    Date of Patent: March 31, 1998
    Assignee: Target Therapeutics, Inc.
    Inventors: Michael P. Wallace, Francisco S. Villar, Nga Thi Van, Nestor Aganon, Delilah Yin Hui
  • Patent number: 5725546
    Abstract: This invention is a surgical instrument, and specifically is a device for delivering embolic coils to a selected site within the vasculature of a human body. This instrument uses, and may include, the catheter used to place the embolic coil. In particular, the device is made up of a pusher wire having a distal tip which is configured to engage the proximal end of an embolic coil. The device may also include a cylindrical pusher which coaxially surrounds at least a portion of the pusher wire and cooperates in the disengagement of the coil from the pusher wire and the ejection of the vasoocclusive coil into the selected vascular site. The pusher wire's engagement tip may be of any selected and convenient shape, and may be grooved, if so desired, to enhance the engagement joint strength.
    Type: Grant
    Filed: June 24, 1994
    Date of Patent: March 10, 1998
    Assignee: Target Therapeutics, Inc.
    Inventor: Gene Samson
  • Patent number: 5722424
    Abstract: This is a surgical instrument. It is a guidewire made of a stainless steel alloy core which is coated with a non-hydrophilic lubricious polymer on the majority of its length located proximally and a hydrophilic polymer located at the majority of the remaining distal length of the guidewire. Preferably, the guidewire has a polymeric tie layer located between the metallic core of the guidewire assembly and the hydrophilic polymeric layer. The metallic core is one of a number of stainless steels so to preserve its torque transmitting capabilities. Desirably the outside diameter of the guidewire is constant from the distal end to the proximal end. The metallic core may be tapered at appropriate locations along the guidewire assembly.
    Type: Grant
    Filed: September 29, 1995
    Date of Patent: March 3, 1998
    Assignee: Target Therapeutics, Inc.
    Inventor: Erik T. Engelson
  • Patent number: 5718711
    Abstract: An exceptionally flexible, ultrasoft vaso-occlusive or embolism forming device made of a material which may be a braid, coil, or chain which forms a long, thin thread-like device having little rigidity or column strength. The device is sufficiently flexible and small that it may be hydraulically delivered to a site within the vasculature of a human body using an injected drug or fluid flush through a catheter.
    Type: Grant
    Filed: May 15, 1995
    Date of Patent: February 17, 1998
    Assignee: Target Therapeutics, Inc.
    Inventors: Alejandro Berenstein, Ivan Sepetka, Uriel Hiram Chee, Wendy J. Zenzen
  • Patent number: 5702373
    Abstract: This is a surgical device. In particular, it is a composite catheter assembly suitable for accessing a tissue target within the body, typically a target which is accessible through the vascular system. Central to the invention is the presence in the catheter assembly of a catheter section having a braided metallic reinforcing member, typically of superelastic alloy ribbon, situated within the reinforced catheter section in such a way to create a catheter having an exceptionally thin wall, controlled stiffness, high resistance to kinking, and complete recovery in vivo from kinking situations. The braid may have a single pitch or may vary in pitch along the axis of the catheter or catheter section. The braided ribbon reinforcing member typically is placed between a flexible outer tubing member and an inner tubing member to produce a catheter section which is very flexible but highly kink resistant.
    Type: Grant
    Filed: August 31, 1995
    Date of Patent: December 30, 1997
    Assignee: Target Therapeutics, Inc.
    Inventor: Gene Samson
  • Patent number: 5700258
    Abstract: A vasoocclusive coil for placement in the vasculature of an animal to form thrombus in a selected site such as an aneurysm or AVM. The device involves a primary coil form having thrombogenic fibers placed on the coil in a specified fashion. The coil will pass through the lumen of a vascular catheter in the primary coil form and evolve into a convoluted or complex secondary form when ejected from the catheter's distal end. The fibers are attached to the coil and cooperate with the coil so that upon ejection from the catheter, the convoluted coil forms a shape in which the central region or secondary coil form center that contains the majority of these fibers.
    Type: Grant
    Filed: September 29, 1995
    Date of Patent: December 23, 1997
    Assignee: Target Therapeutics, Inc.
    Inventors: Gregory E. Mirigian, Nga Thi Van, Son M. Gia
  • Patent number: 5695483
    Abstract: This invention is a surgical device. In particular, it is a catheter suitable for treating a tissue target within the body, which target is accessible through the vascular system. Central to the invention is the use of stiffener ribbons, typically metallic, wound within the catheter body in such a way as to create a catheter having controllable stiffness.
    Type: Grant
    Filed: August 17, 1995
    Date of Patent: December 9, 1997
    Assignee: Target Therapeutics Inc.
    Inventor: Gene Samson
  • Patent number: 5690666
    Abstract: This invention is an exceptionally flexible, ultrasoft vaso-occlusive or embolism forming device. It is made of a radiopaque material which may be braided or coiled to form a long, thin threadlike device having little rigidity or column strength. The diameter of the device may be less than about 0.010 inches. The wire making up the device used to form the coil or braid is typically of a diameter less than about 0.002 inches. The device is sufficiently flexible and small that it may be hydraulically delivered to a site within the vasculature of the human body using an injected drug or fluid flush through a catheter. The device assumes a loose, random mass of threadlike material after being ejected from the catheter tip at the chosen vascular site.
    Type: Grant
    Filed: November 18, 1992
    Date of Patent: November 25, 1997
    Assignee: Target Therapeutics, Inc.
    Inventors: Alejandro Berenstein, Ivan Sepetka
  • Patent number: 5683410
    Abstract: This invention is a single-lumen balloon catheter having a valve seat on the distal end of the catheter, distal of the balloon, which may be operated by a control wire having a valve plug disposed on the wire. The valve seat may be engaged by the valve plug from either direction, depending on the installation of the control wire. In either event, if the valve plug is installed distally of the valve seat in the catheter lumen, the valve is closed by pulling on the control wire (or moving the control wire in a proximal direction) and introducing fluid through the catheter lumen through the balloon. Alternatively, the guidewire, with its integral valve plug, may be introduced from the proximal end of the catheter and may traverse the body of the balloon to engage the valve seat in the distal end of the catheter. Pushing on the control wire will seat the valve, allowing the introduction of fluid through the catheter lumen to inflate the balloon.
    Type: Grant
    Filed: April 27, 1995
    Date of Patent: November 4, 1997
    Assignee: Target Therapeutics, Inc.
    Inventor: Gene Samson
  • Patent number: 5669931
    Abstract: An occlusive implant includes an elongated member having an end, a portion proximal to that end, and a portion distal to that end. The proximal portion is sufficiently flexible so that it can be folded upon itself and maintain that configuration without further restraint. At least a portion of the distal portion is preformed to have a first configuration when in a first state and a second configuration when in a second state. The distal portion second configuration has a flow resistance substantially greater than that of the proximal portion. When discharged in the region to be occluded, the proximal portion is forced into a mass around at least a portion of the distal portion secondary structure. As the mass builds in size, it is believed to frictionally engage the surrounding vasculature wall and anchor the implant thereto. The occlusive implant preferably is provided in an introducer cartridge for delivery in vivo.
    Type: Grant
    Filed: April 2, 1996
    Date of Patent: September 23, 1997
    Assignee: Target Therapeutics, Inc.
    Inventors: David Kupiecki, Cong Thach, John E. Ortiz, Neil J. Sheehan
  • Patent number: 5669905
    Abstract: This invention is a method for ensuring for endovascular occlusion through the formation of thrombi in arteries, veins, aneurysms, vascular malformations, and arteriovenous fistulas. In particular, it deals with a method to predictably determine the instant of electrolytic detachment of an embolic device which is introduced to and is intended to remain at the desired thrombus formation site. The invention further includes a method for delivering an embolic device and detecting its electrolytic separation. According to the present invention, DC power with AC superposition is delivered to the sacrificial link that couples a delivery member (e.g., a guidewire) to an occlusion device. The impedance (as measured by the amplitude of the superposed AC) is monitored. When a predetermined change in that impedance (or amplitude occurs), which indicates coil detachment, the DC power is interrupted to minimize or avoid further electrolysis.
    Type: Grant
    Filed: July 11, 1995
    Date of Patent: September 23, 1997
    Assignee: Target Therapeutics, Inc.
    Inventors: Ronald W. Scheldrup, Laurent B. Schaller
  • Patent number: 5658308
    Abstract: A thrombogenic occlusion coil for occluding a blood vessel comprising a helical metallic coil having a plurality of axially spaced windings and a plurality of strands of a thrombogenic polymer extending axially through the central core of the coil, the ends of the strands being bound together.
    Type: Grant
    Filed: December 4, 1995
    Date of Patent: August 19, 1997
    Assignee: Target Therapeutics, Inc.
    Inventor: Edward J. Snyder
  • Patent number: 5658264
    Abstract: This invention is a surgical device. In particular, it is a catheter suitable for accessing a tissue target within the body, typically a target which is accessible through the vascular system. Central to the invention is the use of a stiffener ribbon, typically metallic, wound within the catheter body in such a way as to create a catheter having controllable stiffness. The stiffener ribbon is adhesively bonded to a flexible outer tubing member so to produce a thin wall catheter section which is exceptionally flexible but highly kink resistant. The catheter sections made according to this invention may be used in conjunction with other catheter sections either using the concepts shown herein or made in other ways. Because of the effective strength and ability to retain a generally kink-free form, these catheters may be effectively used in sizes which are quite fine, e.g., 0.015" to 0.020" in diameter, and usable within typical vascular catheters.
    Type: Grant
    Filed: November 10, 1994
    Date of Patent: August 19, 1997
    Assignee: Target Therapeutics, Inc.
    Inventor: Gene Samson
  • Patent number: 5649949
    Abstract: This is an implantable vasoocclusive device. It is constructed of a primary helically wound coil, which primary coil is further wound into secondary shapes which are at least partially substantially conical. Other portions of the secondary shape may have sections of constant diameter or of other conical shapes. The primary coil may be made in such a way that it has regions of differing flexibility. Fibrous materials may be placed on the coils in tufted, streamer, or woven configurations so to increase the thrombogenicity of the overall assembled device.
    Type: Grant
    Filed: March 28, 1996
    Date of Patent: July 22, 1997
    Assignee: Target Therapeutics, Inc.
    Inventors: Michael P. Wallace, Francisco S. Villar, Christopher G. M. Ken, David A. Gyorke, Timothy S. Winkle
  • Patent number: 5649978
    Abstract: This invention is in the general field of surgical instruments and relates specifically to an inflatable prosthetic device suitable for use in cardiovascular or endovascular procedures, such as angioplasty, to restore normal blood flow through the vessel. The device is generally a helically wound balloon having a false lumen through its center which is inflatable through its integral inflation lumen.
    Type: Grant
    Filed: October 25, 1994
    Date of Patent: July 22, 1997
    Assignee: Target Therapeutics, Inc.
    Inventor: Gene Samson
  • Patent number: 5643254
    Abstract: This invention is a method for ensuring for endovascular occlusion through the formation of thrombi in arteries, veins, aneurysms, vascular malformations, and arteriovenous fistulas. In particular, it deals with a method to predictably determine the instant of electrolytic detachment of an embolic device which is introduced to and is intended to remain at the desired thrombus formation site. The invention further includes a method for delivering an embolic device and detecting its electrolytic separation.
    Type: Grant
    Filed: November 21, 1995
    Date of Patent: July 1, 1997
    Assignee: Target Therapeutics, Inc.
    Inventors: Ronald W. Scheldrup, Laurent B. Schaller
  • Patent number: 5639277
    Abstract: This is a surgical device that, in particular, is for forming a vasoocclusion or embolism. Typically, it is a helically wound coil in which the helix is wound in such a way as to have multiple axially offset, longitudinal or focal axes. Another important facet of the invention is the presence of small diameter secondary coil windings adjacent large diameter coil windings. The device is sufficiently flexible and small that it may be delivered to a site within the vasculature of the human body using a pusher and a catheter. The device is generally linear when within the catheter but relaxes to form the multi-focal form after delivery from the distal end of the catheter lumen. Various mechanical connections may also be used to discharge the inventive coil from its pusher. Similarly, the coil may be attached to a pusher using a sacrificial joint, which sacrificial joint is dissolved by imposition of a small voltage within the human body.
    Type: Grant
    Filed: September 29, 1995
    Date of Patent: June 17, 1997
    Assignee: Target Therapeutics, Inc.
    Inventors: Michael J. Mariant, Gregory E. Mirigian, Nga T. Van, Roberto L. Orellana, Christopher G. M. Ken
  • Patent number: 5636642
    Abstract: This invention is a surgical device. It is a guidewire for use in a catheter and is used for accessing a targeted site within a system of lumen within a patient's body. The guidewire may be of a high elasticity metal alloy, preferably a Ni--Ti alloy, having specified physical parameters, and is especially useful for accessing peripheral or soft tissue targets. The "necked" guidewire tip also forms a specific parameter of the invention.
    Type: Grant
    Filed: April 25, 1995
    Date of Patent: June 10, 1997
    Assignee: Target Therapeutics, Inc.
    Inventor: Thomas J. Palermo
  • Patent number: 5624461
    Abstract: This is an implantable vaso-occlusive device. It is a complex, helically wound coil comprised of a primary helically wound coil which is then wound into a specific secondary shape. The final shape upon deployment is in the approximate shape of an anatomical cavity. upon deployment, the device first fills the periphery of the cavity and then continues to infill the center. The device is a self-forming shape made from a pre-formed linear helically wound. Fibers may be introduced onto the device and affixed to the pre-formed linear member. The constituent member may be also be covered with a fibrous braid. The device is typically introduced through a catheter. The device is passed axially through the catheter sheath and assumes its form upon exiting the catheter without further action. The invention also includes methods of winding the vaso-occlusive device into appropriately shaped forms and annealing them.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: April 29, 1997
    Assignee: Target Therapeutics, Inc.
    Inventor: Michael J. Mariant
  • Patent number: 5603991
    Abstract: This invention is in the general field of surgical instruments and, in particular, catheters. Specifically, it relates to procedures for coating the interior surfaces of surgical devices with a cross-linkable lubricious polymer, preferably one which is hydrophilic. These catheters may be variously used in cardiovascular and endovascular procedures to deliver diagnostic, therapeutic, or vaso-occlusive agents or devices to a target site within a human or animal body and to catheters used to guide other catheters to a particular site in that body. The interior of the catheters are coated using the noted procedure in such a way that the interior is exceptionally slippery and very durable.
    Type: Grant
    Filed: September 29, 1995
    Date of Patent: February 18, 1997
    Assignee: Target Therapeutics, Inc.
    Inventors: David Kupiecki, Thuzar K. Han